CompoAtlas

Joint Solution

Joint Solution, licence 80088885: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Other names
Joint Relief Solution
Licence holder
Canadian Health Empire
NPN or DIN-HM
80088885
Status
Active licence
Licence date
24 October 2018
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Sulfate de 2-amino-2-désoxy-D-glucose

Source : Glucosamine Sulfate Potassium derived from shrimp and crab

500.0 milligrammeNot calculated
Méthylsulfonylméthane

Source : Sulfone de diméthyl

150.0 milligrammeNot calculated
Camellia sinensis

Source : Camellia sinensis - feuille

10.0 milligrammeNot calculated
Curcuma longa

Source : Curcuma longa - Racine

10.0 milligrammeNot calculated
Collagène hydrolysé

Source : Collagène hydrolysé

50.0 milligrammeNot calculated
Trans-resvératrol

Source : Resvératrol

10.0 milligrammeNot calculated

Non-medicinal ingredients

Not provided.

PopulationAgeQuantity per servingFrequency
AdultesNot specified1.0 Comprimé1.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to relieve joint pain associated with osteoarthritis (of the knee). Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and/ or joint health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80088885

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line